Subscribe to our: Posted on 2006/10/24 20:00:00 (2687 reads)
Viron Therapeutics, Inc. signed an agreement with Diosynth Biotechnology for process development, scale-up, and clinical manufacturing for their lead product candidate.
Read More... | 6346 bytes more
General : Diosynth Biotechnology Enters Long-term Commercial Supply Agreement With Dendreon Corporation
Posted on 2006/3/2 16:20:00 (3626 reads)
Diosynth Biotechnology announced today that it has entered into a long-term commercial supply agreement with Dendreon Corporation (NASDAQ: DNDN) for the manufacture of the recombinant antigen component of PROVENGE? (sipuleucel-T), Dendreon’s investigational active cellular immunotherapy for prostate cancer.
Read More... | 6021 bytes more
Posted on 2005/9/22 20:00:00 (2182 reads)
Vernalis Plc has signed a contract with Diosynth Biotechnology for process development, scale-up and manufacturing of V10153 for Phase III clinical trials.
Read More... | 5342 bytes more
Posted on 2005/9/21 20:10:00 (2669 reads)
Diosynth Biotechnology today announced that it has agreed to an amendment of the current agreement it has with NeoPharm, Inc. (Nasdaq: NEOL) to provide for Diosynth's performing validation and conformance lot manufacturing of NeoPharm's cintredekin besudotox (IL13-PE38QQR) drug candidate in the event NeoPharm is able to move forward with a Biologic License Application (BLA) at the conclusion of its pivotal Phase III PRECISE trial for cintredekin besudotox.
Read More... | 6510 bytes more
|
Biotechnology Contract Manufacturing Services
